-
January 18, 2010
Severe form of psoriasis ups heart disease risk
NEW YORK (Reuters Health) - People with severe forms of the inflammatory skin disease psoriasis are more likely to die of heart-related causes and stroke than those without the condition, new research shows.
-
December 29, 2009
Itchy skin can be psychologically stressful
NEW YORK (Reuters Health) - Chronically itchy skin can take not only a physical toll but a psychological one as well, a new study suggests.
-
November 25, 2009
Experts scan disease links with Chinese "gene map"
HONG KONG (Reuters) - A large analysis of the genes of 8,200 ethnic Chinese has revealed subtle genetic differences between inhabitants in northern China and southern China, and even between different Chinese dialect groups.
-
November 5, 2009
Psoriatic arthritis common in people with psoriasis
NEW YORK (Reuters Health) - As many as 14 percent of people with psoriasis may also have psoriatic arthritis, research shows.
-
August 4, 2009
Arthritis drugs raise cancer risk in kids: US FDA
WASHINGTON (Reuters) - Blockbuster prescription drugs used to treat rheumatoid arthritis and other conditions can increase the risk of potentially deadly cancer in children and teenagers, U.S. health regulators said on Tuesday in ordering stronger warnings on such medications.
-
July 16, 2009
Psoriasis treatment may up cancer risk
NEW YORK (Reuters Health) - Patients with moderate to severe psoriasis may need life-long treatment with a variety of therapies to relieve symptoms of the scaly skin condition and research has shown that both traditional and newer therapies for psoriasis can increase patients' risk of certain cancers.
-
July 1, 2009
Heart disease increases with psoriatic arthritis
NEW YORK (Reuters Health) - Patients with psoriatic arthritis have an increased risk of cardiovascular disease, according to findings published in the Annals of Rheumatic Diseases.
-
June 16, 2009
Psoriasis linked to strokes and death
NEW YORK (Reuters Health) - People with psoriasis, a common scaly skin condition, are at increased risk for strokes, heart disease, and circulatory problems in the legs, new research shows.
-
April 20, 2009
Psoriasis linked to diabetes, hypertension
CHICAGO (Reuters) - Women with psoriasis run a higher risk of diabetes and high blood pressure, perhaps because of the underlying inflammation that causes the skin condition, researchers said on Monday.
-
April 9, 2009
Genentech withdraws psoriasis drug from US market
LOS ANGELES (Reuters) - Genentech Inc. announced Wednesday a phased voluntary withdrawal of psoriasis drug Raptiva from the U.S. market due to its link to a brain infection.
-
December 22, 2008
Abnormal ECG seen in psoriatic arthritis patients
NEW YORK (Reuters Health) - The results of a new study suggest that patients with psoriatic arthritis, a form of rheumatoid arthritis accompanied by psoriasis, may have "subtle" cardiac conduction disturbances. Researchers point out, however, that it is not yet known if these irregularities lead to serious heart disease.
-
November 26, 2008
Indigo extract effective treatment for psoriasis
NEW YORK (Reuters Health) - Taiwanese investigators report that an ointment made from an extract of Indigo naturalis is effective in treatment-resistant plaque psoriasis -- and the treatment appears to be safe.
-
November 26, 2008
Scientists shed light on causes of epilepsy
LONDON (Reuters) - A breakdown in a reaction between immune cells and blood vessels in the brain appears to play a key role in epilepsy, Italian researchers said on Monday.
-
November 24, 2008
Scientists shed light on causes of epilepsy
LONDON (Reuters) - A breakdown in a reaction between immune cells and blood vessels in the brain appears to play a key role in epilepsy, Italian researchers said on Monday.
-
November 18, 2008
Merck KGaA works with regulators on brain infection
FRANKFURT (Reuters) - Merck KGaA, the drugmaker that markets Genentech's psoriasis drug Raptiva in Europe, said it is working with European Union regulators after a second Raptiva patient died of a rare brain infection in the United States.
-
November 6, 2008
Green tea compound may prevent diabetes: study
NEW YORK (Reuters Health) - A compound found in green tea could slow or even prevent the development of type 1 diabetes, new research in mice suggests.
-
October 21, 2008
Many biological medicines draw safety warnings
WASHINGTON (Reuters) - About a quarter of biological medicines approved in the United States and Europe since 1995 have triggered safety warnings in the years after entering the market, Dutch researchers said on Tuesday.
-
October 17, 2008
U.S. calls for new warnings on Genentech skin drug
WASHINGTON (Reuters) - U.S. health regulators have ordered strong black-box warnings for Genentech Inc's psoriasis drug, Raptiva, saying patients given the once-weekly injections are at risk for life-threatening infections.
-
August 6, 2008
Many people don't get prescriptions filled
NEW YORK (Reuters Health) - One in three people who are prescribed medications may never get them filled, a new study in patients being treated for skin conditions has found.
-
June 18, 2008
US panel backs wider use of Amgen drug for kids
SILVER SPRING, Md. (Reuters) - U.S. health officials should approve wider use of Amgen Inc's drug Enbrel to treat psoriasis in children, a Food and Drug Administration advisory panel said on Wednesday.
-
June 18, 2008
FDA panel backs proposed J&J psoriasis drug
SILVER SPRING, Maryland (Reuters) - Johnson & Johnson's experimental drug ustekinumab should be approved for treating adults with moderate or severe psoriasis, a U.S. advisory panel unanimously ruled on Tuesday.
-
June 16, 2008
Amgen's Enbrel in kids 'concerning,' FDA staff says
WASHINGTON (Reuters) - U.S. drug regulators are concerned about life-threatening complications in children taking Amgen Inc's drug Enbrel for psoriasis and other conditions, according to documents released on Monday.
-
June 4, 2008
US probes cancer in children given arthritis drugs
WASHINGTON (Reuters) - U.S. health officials are investigating whether drugs for rheumatoid arthritis and Crohn's disease are linked to cancers in children and young adults, the Food and Drug Administration said on Wednesday.
-
May 14, 2008
Arthritis may be triggered by environmental factors
NEW YORK (Reuters Health) - A number of environmental exposures, including trauma, are associated with the onset of inflammatory arthritis in patients with psoriasis, findings published in the Annals of the Rheumatic Diseases indicate.
-
May 1, 2008
Immune drug useful for scalp psoriasis
NEW YORK (Reuters Health) - Alefacept, a drug that reduces the activity of certain immune cells, is effective in treating psoriasis of the scalp, according to a report in the Journal of the American Academy of Dermatology.
-
May 1, 2008
No effective treatments for patchy hair loss
NEW YORK (Reuters Health) - There is no good evidence for any long-term benefit of any treatments now available for patchy hair loss, a type of baldness called alopecia areata, the authors of a review of current research on the subject conclude.
-
April 18, 2008
New immune drug safely treats psoriasis: study
WASHINGTON (Reuters) - An experimental new drug that suppresses certain parts of the immune system worked safely to relieve some of the symptoms of psoriasis, researchers in Canada reported on Thursday.
-
March 26, 2008
Diabetes drugs may prevent psoriasis
NEW YORK (Reuters Health) - The use of "thiazolidinediones" type diabetes drugs, such as Avandia and Actos, may reduce the risk of developing the scaly skin condition psoriasis, according to Swiss and US researchers.
-
February 22, 2008
Vietnam vet study links PTSD to mortality risk
NEW YORK (Reuters Health) - Post-traumatic stress disorder is nearly as powerful a predictor of the likelihood of dying over a 15-year period as an abnormal score on two laboratory tests commonly used to gauge overall health, a new study in Vietnam veterans demonstrates.
-
February 8, 2008
Psoriatic arthritis does not raise risk of cancer
NEW YORK (Reuters Health) - Overall, people who suffer from psoriatic arthritis do not appear to have a higher risk of cancer compared to the general population, according to a new study.
-
February 6, 2008
Psoriasis drug may provide lasting relief: study
NEW YORK (Reuters Health) - The drug alefacept, which in 2003 was the first "biologic" agent approved in the US for the treatment of moderate to severe chronic plaque psoriasis, appears to be a long-term option for certain patients, results of a study suggests.
-
December 17, 2007
Some psoriasis linked to higher death rates: study
CHICAGO (Reuters) - People who suffer from severe psoriasis die younger than people with mild cases or without the disease, for reasons that are unclear, researchers said on Monday.
-
November 6, 2007
Smoking may raise psoriasis risk
NEW YORK (Reuters Health) - Pointing to yet another health consequence of smoking, a new study suggests that the habit raises the risk of the skin disease psoriasis.
-
October 8, 2007
Psoriasis patients' adjust to adverse reactions
BUENOS AIRES (Reuters Health) - Psoriasis patients learn to cope when others show disgust in response to their skin lesions by automatically shutting off a specific part of their brains, UK researchers report.
-
October 4, 2007
New psoriasis drug is safe and effective
BUENOS AIRES (Reuters Health) - A new psoriasis drug, which could be self-injected every 3 months, had "impressive" safety and efficacy results in a late-stage, multicenter clinical trial involving more than 1,200 patients with chronic plaque psoriasis, researchers announced here at the World Congress of Dermatology.
-
October 3, 2007
Psoriasis drug shown highly effective in trial
NEW YORK (Reuters) - Johnson & Johnson's experimental treatment for psoriasis proved safe and highly effective in a late-stage trial, positioning it as a potential strong rival to current medicines, the company said on Wednesday.
-
October 1, 2007
Abbott drug maintains psoriasis relief in trial
NEW YORK (Reuters) - A high percentage of patients taking Abbott Laboratories Inc's experimental psoriasis drug, ABT-874, maintained an impressive improvement in symptoms 12 weeks after discontinuing the treatment, the drugmaker said on Monday.
-
September 24, 2007
Anorexic woman used to push Italian fashion brand
ROME (Reuters) - A photograph of a naked anorexic woman appeared on Monday in Italian newspapers and on billboards to highlight the effects of the illness during Milan fashion week while promoting a fashion brand.
-
August 23, 2007
Being overweight may raise women's psoriasis risk
NEW YORK (Reuters Health) - Women who are overweight or obese may face a higher risk of developing the psoriasis, a common skin condition, a large study suggests.
-
July 10, 2007
Arthritis drug may treat stubborn psoriasis
NEW YORK (Reuters Health) - Patients with severe psoriasis previously treated with Enbrel (also known as etanercept) may respond to Remicade (also known as infliximab), a study published this month suggests.
-
June 18, 2007
Enbrel works well for psoriasis over long term
NEW YORK (Reuters Health) - The symptoms of moderate-to-severe psoriasis are improved by treatment with Enbrel, known generically as etanercept, and the therapy remains safe and effective for up to 96 weeks, according to a new study
-
June 14, 2007
Europe lagging in access to arthritis drugs
BARCELONA (Reuters) - European patients are lagging those in the United States in getting access to modern rheumatoid arthritis drugs, while inequalities within Europe aggravate the problem further, doctors said on Thursday.
-
March 7, 2007
It's true -- stress makes teens break out
WASHINGTON (Reuters) - Teen-agers who claim that stress makes them break out are telling the truth: The stress of taking an exam can make pimples worse, researchers reported on Tuesday.
-
February 13, 2007
Insecure relationships may drain immune system
NEW YORK (Reuters Health) - Feeling insecure in close relationships with others may take a toll on the immune system, preliminary research suggests.